MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
*Driving Forces: Market Research, Intelligence, Analysis, Datapoints, Databases & Trends
2023: Top 20 Genomics Companies in the World
Anavex Life Sciences Corp. (NASDAQ:AVXL)*
Organization & Developments: Anavex
Parents
Anavex Life Sciences Corp. (NASDAQ:AVXL)*
Children
2018: Anavex_Our Take On $2.50 Lottery Ticket
2021: Alzheimer's - Cassava, Cortexyme Or Anavex: Who Will Come On Top?
2022: Anavex Life Sciences: Market Unimpressed As Major Alzheimer's Data Readout Arrives_ seekingalpha.com
2022: Anavex Life Sciences: Upcoming Readouts In Alzheimer's And Parkinson's Disease Dementia_seekingalpha.com
2022: Anavex's Alzheimer's Results Leave Much To Be Desired_ seekingalpha.com
2022: Anavex's Blarcamesine And Other Disease Modifying Treatments For Alzheimer's Disease_seekingalpha.com
2023: Anavex Life Sciences: Rett Safety Dance With Broader CNS Implications (Rating Downgrade)_ seekingalpha.com
2023: Anavex: The September Data
2024: Anavex gains as lead asset slows Alzheimer’s disease progression by a third_MSN
2024: Anavex Life Sciences Corp. (NASDAQ:AVXL): Is Breakeven Near?
2024: Anavex Life Sciences: Jumping In On Time Ahead Of An Early Alzheimer's Decision
2024: Anavex Life Sciences: Why I Am Still Not Buying The Bull Thesis
2024: Anavex stock sinks 30% as lead asset fails to improve Rett syndrome in children
2024: Anavex Stock: A Risky Bet On CNS Drug Development (Rating Downgrade)
2024: Anavex: EU Approval Application Is A Precipitous Moment
2024: Anavex: The Pediatric Rett Trial Failure Is Disastrous_ seekingalpha.com
2024: Anavex: Understanding Their Latest Alzheimer's Data News With Caution
2024: Anavex’s Blarcamesine Achieves Pre-specified Efficacy in Phase IIb/III Alzheimer’s Trial: Data Presented at CTAD Conference 2024
2025: Anavex Seeks EU Approval, But The Data Says Otherwise
2025: Anavex: Further Validation Of Blarcamesine With Schizophrenia Data In 2025
2025: Anavex: Looking At Different Statistical Approaches Before EMA Opinion_seekingalpha.com
2025: Playing The Odds Of Anavex Alzheimer's Drug Approval_seekingalpha.com
2025: The Misconceptions About Anavex Life Sciences' Blarcamesine Phase 2b/3 Trial In Alzheimer's Disease
Jumps
Finance & Acquisitions: Anavex
Key People: Anavex